Skip to content
TrialScanner

NCT05218408

CYNK-001 IV and IC in Combination With IL2 in Surgical Eligible Recurrent GBM With IDH-1 Wild Type

Phase 1/Phase 2WithdrawnCELULead

Registry record

Lead sponsor
Celularity Incorporated
Conditions
Astrocytoma, Grade IV; Glioblastoma; Giant Cell Glioblastoma; Glioblastoma Multiforme
Primary completion
Oct 23, 2021Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT05218408 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT05218408: CYNK-001 IV and IC in... | TrialScanner